Replay LSI2021 Emerging Medtech Summit

Play Now
innovation hub

Augmenix (Acquired) is Profiled in this Database

Updated At 20 Feb, 2021

Start Free 7 Day Trial Now
Partial description of this company
1-Hydrogel soft tissue marker that is fully absorbable and visible under several imaging modalities and 2-Absorbable hydrogel spacer that reduces radiation injury to the rectal wall in men undergoing prostate radiotherapy

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of Augmenix (Acquired) plus 4972 other startups.

Start Free 7 Day Trial Now

Learn More About Augmenix (Acquired)

Technology/product details

Potential acquirers

Revenue projections

Capital raised to date

Growth strategy

Market landscape

CEO presentation

More

Our Clients